SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotechnology Value Fund, L.P.
An SI Board Since January 1998
Posts SubjectMarks Bans
4974 145 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromPosted
2974Message 17397356 Doc: I bought something hand over fist this morning, but thenscaram(o)uche4/29/2002
2973<i>last time I go on vacation and leave you guys/gals in charge! </i>nigel bates4/29/2002
2972<i>I'm a short-term counter indicator, huh?</i> But great on thDoc Bones4/29/2002
2971>> Usually biotech drops about 20% from there << Chuckle. I'm scaram(o)uche4/29/2002
2970wow. six trading days, and ^BTK loses 13%. large cap biotech is trying to catcscaram(o)uche4/29/2002
2969Rick, Let us know when you start buying with both hands. Usually biotech dropsDoc Bones4/25/2002
2968Rick, Right but btk breached support 450 so now we have some at 400 and then cdalroi4/25/2002
2967full frontal attack on biotech..... funds selling in the face of a constant fscaram(o)uche4/25/2002
2966Dynavax Raises $34.8 Million in Private Equity Round Led by Care Capital BERKELnigel bates4/25/2002
2965out the door, emphasis mine....... Wednesday April 24, 10:12 pm Eastern Time Prscaram(o)uche4/25/2002
2964>> still holding cash and a couple of hunker, scalping. << I startescaram(o)uche4/24/2002
2963Yale infuses $200 million for bioresearch Walter Kita, Register staff April 24, Jim Oravetz4/24/2002
2962market cap is 9 billion, one product (sorta) company..... let the shorts comescaram(o)uche4/24/2002
2961SAN DIEGO--(BW HealthWire)--April 24, 2002--IDEC Pharmaceuticals Corporation (Nanigel bates4/24/2002
2960CARLSBAD, Calif., April 23 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. nigel bates4/23/2002
2959IPO Outlook: Biotech Gets Its Shot In An Uncertain Market By RAYMOND HENNESSEY mopgcw4/22/2002
2958Spot on analysis. "all existing investors" Axovan Secures $18.2 Millmopgcw4/22/2002
2957What's wrong with this picture? <b>OTHER THAN IT'S 2 1/2 YEARS TOscaram(o)uche4/22/2002
2956ALLSCHWIL and BASEL, Switzerland, April 22 /PRNewswire/ -- AXOVAN AG today announigel bates4/22/2002
2955Canada's YM BioSciences Plans To Float In London, Toronto DOW JONES NEWSWIRmopgcw4/21/2002
2954That is discouraging, to me, since the VCs will hew to their ridiculous mezzaninkeokalani'nui4/21/2002
2953an on-topic snippet from last week's BioCentury...... <b>Window-wishescaram(o)uche4/21/2002
2952Wilder..... I decided to change my answer re. paragraph two. Yes, some good scaram(o)uche4/20/2002
2951MON, 4/22/2002, 4:00 PM Peter Schultz, Scripps Institute/Genomics Inst. of Novarscaram(o)uche4/20/2002
2950nominated for post of the year. First paragraph, nail on head. Second paragrapscaram(o)uche4/19/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News